Skip to main content
. 2014 Jan 28;18(2):253–262. doi: 10.1111/jcmm.12228

Fig 5.

Fig 5

Lung specimens from controls (A–C and G) and patients with systemic sclerosis (SSc) (D–F and H). (A–F) CD34 immunoperoxidase labelling with haematoxylin counterstain. (G and H) Double immunofluorescence labelling for CD34 (green) and CD31 (red) with DAPI (blue) counterstain for nuclei. (A–C) In control lung parenchyma, telocytes are broadly distributed in the interstitial space around alveoli and bronchioles. Telocytes also encircle blood vessels (inset in A) and are located around smooth muscle bundles within the wall of bronchioles (inset in B). At higher magnification view, lung telocytes display a slender nucleated body and two long varicose processes extending in the pulmonary interstitium (inset in C). (D–F) In the fibrotic lung of SSc patients, very few or no telocytes are observed in the thickened alveolar septa and in the interstitial space surrounding terminal and respiratory bronchioles, around blood vessels (inset in D) and smooth muscle bundles within the wall of bronchioles (inset in E). (G and H) Pulmonary telocytes are CD34-positive and CD31-negative, while vascular endothelial cells are CD34/CD31-double-positive. Inset: Higher magnification view of a telocyte with two long cellular extensions. TB: terminal bronchiole. Scale bars are indicated in each panel.